InvestorsHub on MSN
VolitionRx shares jump as feline cancer blood test delivers strong accuracy results
Volitionrx Ltd (NYSE:VNRX) shares rallied 18.5% on Thursday after the company unveiled encouraging performance data for its ...
VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces results from a clinical study demonstrating the high accuracy of its Nu.Q® Vet Feline assay in ...
The tests have not been approved by federal regulators, but that hasn’t stopped patients from wanting them — and doctors from worrying. By Nina Agrawal In the spring of 2021, the cancer field was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback